Telehealth startup Cerebral adjusted its marketing and advertising strategies to reflect the suspension of controlled substance prescriptions for new patients after allegations of overprescribing by providers surfaced, M+MM reported May 10.
Copyright © 2024 | WordPress Theme by MH Themes